2,4-Dichlorphenyl-2-aminophenylsulfid | 33253-19-9

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 2,4-Dichlorphenyl-2-aminophenylsulfid
• 英文别名: 2-(2,4-Dichlorophenyl)sulfanylaniline
• CAS: 33253-19-9
• 化学式: C₁₂H₉Cl₂NS
• 分子量: 270.182
• InChiKey: MTECIBNABLABNT-UHFFFAOYSA-N

物化性质

• 沸点：
  367.1±42.0 °C(Predicted)
• 密度：
  1.42±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  51.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2,4-Dichlorphenyl-2-aminophenylsulfid 在 三乙胺 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 17.0h， 生成 N-[2-(2,4-Dichloro-phenylsulfanyl)-phenyl]-3-(4-methyl-piperazin-1-yl)-propionamide
  参考文献：
  名称：

  Discovery of Novel p-Arylthio Cinnamides as Antagonists of Leukocyte Function-Associated Antigen-1/Intracellular Adhesion Molecule-1 Interaction. 1. Identification of an Additional Binding Pocket Based on an Anilino Diaryl Sulfide Lead

  摘要：

  The interaction between leukocyte function-associated antigen-1 (LFA-1), a member of the beta (2)-integrin family of adhesion molecules, and intracellular adhesion molecule ICAM-1 (cd54) is thought to play a critical role in the inflammatory process. On the basis of an anilino diaryl sulfide screening lead 1, in combination with pharmacophore analysis of other screening hits, we have identified an adjacent binding pocket. Subsequently, a p-ethenylcarbonyl linker was discovered to be optimal for accessing this binding site. Solution-phase parallel synthesis enabled rapid optimization of the cinnamides for this pocket. In conjunction with fine-tuning of the diaryl substituents, we discovered a novel series of potent, nonpeptide inhibitors of LFA-1/ICAM-1 interaction, exemplified by A-286982 (28h), which has IC50 values of 44 and 35 nM in an LFA-1/ICAM-1 binding assay and LFA-l-mediated cellular adhesion assay, respectively.

  DOI：

  10.1021/jm0002782
• 作为产物：
  描述：

  2,4-二氯苯硫酚 在 乙醇 、 potassium carbonate 、 tin(ll) chloride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 6.5h， 生成 2,4-Dichlorphenyl-2-aminophenylsulfid
  参考文献：
  名称：

  Discovery of Novel p-Arylthio Cinnamides as Antagonists of Leukocyte Function-Associated Antigen-1/Intracellular Adhesion Molecule-1 Interaction. 1. Identification of an Additional Binding Pocket Based on an Anilino Diaryl Sulfide Lead

  摘要：

  The interaction between leukocyte function-associated antigen-1 (LFA-1), a member of the beta (2)-integrin family of adhesion molecules, and intracellular adhesion molecule ICAM-1 (cd54) is thought to play a critical role in the inflammatory process. On the basis of an anilino diaryl sulfide screening lead 1, in combination with pharmacophore analysis of other screening hits, we have identified an adjacent binding pocket. Subsequently, a p-ethenylcarbonyl linker was discovered to be optimal for accessing this binding site. Solution-phase parallel synthesis enabled rapid optimization of the cinnamides for this pocket. In conjunction with fine-tuning of the diaryl substituents, we discovered a novel series of potent, nonpeptide inhibitors of LFA-1/ICAM-1 interaction, exemplified by A-286982 (28h), which has IC50 values of 44 and 35 nM in an LFA-1/ICAM-1 binding assay and LFA-l-mediated cellular adhesion assay, respectively.

  DOI：

  10.1021/jm0002782

文献信息

• Reduction of nitro- and nitroso-compounds by tervalent phosphorus reagents. Part IX. The ‘blocked ortho’ effect in reactions of 2,6-di-substituted aryl 2-nitrophenyl and 2,6-disubstituted aryl 2-azidophenyl sulphides: a new series of nitrene-induced aromatic rearrangements
  作者：J. I. G. Cadogan、S. Kulik

  DOI：10.1039/j39710002621

  日期：——

  thermolysis of the corresponding 2-azido-derivatives proceed via rearrangement involving a free ortho-position in the aryl group to give phenothiazines, corresponding reactions involving nitro-compounds and azides in which both ortho-positions are blocked have been carried out. These have led to a new series of aromatic rearrangements whereby 2-nitrophenyl 2,6-dimethyl-, 2,6-dimethoxy-, 2,6-dichloro-

  鉴于有证据表明，将芳基2-硝基苯基硫化物与亚磷酸三乙酯脱氧并进行相应的2-叠氮基衍生物的热解是通过重排进行的，该重排涉及芳基中的游离邻位，从而产生吩噻嗪，相应的反应涉及硝基化合物和已经完成了两个邻位都被阻断的叠氮化物。这些导致了一系列新的芳族重排，其中2-硝基苯基2,6-二甲基-，2,6-二甲氧基-，2,6-二氯-，2-氯-6-甲基-，2,4,6-三甲基和2,6-二乙氧基羰基苯基硫化物以及（除了姓氏例外）相应的2-叠氮基衍生物分别转化为5,11-二氢-4-甲基二苯并[ b，e] [1,4] thiazepine（17），1-和1,2-二甲氧基吩噻嗪（通过新型的脱甲氧基作用和1,4-甲氧基基团转移），1-和4-氯吩噻嗪，1-和4-甲基吩噻嗪， 5,11-二氢-2,4-二甲基二苯并[ b，e ] [1,4]噻嗪（23）和4a H-吩噻嗪-1,4a-二羧酸二乙酯（50）。在两种氯取代的衍生物的情
• Aryl carbonyl derivatives as therapeutic agents
  申请人：——

  公开号：US20040122235A1

  公开（公告）日：2004-06-24

  This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.

  本发明涉及芳基羰基衍生物，其是葡萄糖激酶的激活剂，可用于管理、治疗、控制或辅助治疗增加葡萄糖激酶活性有益的疾病。
• Phenothiazine kinesin inhibitors
  申请人：——

  公开号：US20040132719A1

  公开（公告）日：2004-07-08

  Phenothiazine derivatives of formula (I) are disclosed. The compounds are inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases, such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. 1

  公开了公式（I）的苯并噻唑衍生物。这些化合物是有丝分裂动力蛋白KSP的抑制剂，可用于治疗细胞增殖性疾病，如癌症、增生、再狭窄、心脏肥大、免疫失调和炎症。
• ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS
  申请人：Polisetti Dharma Rao

  公开号：US20110301158A1

  公开（公告）日：2011-12-08

  This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.

  本发明涉及芳基羰基衍生物，它们是葡萄糖激酶的活化剂，可能有助于管理、治疗、控制或辅助治疗增加葡萄糖激酶活性有益的疾病。
• PHENOTHIAZINE KINESIN INHIBITORS
  申请人：Cytokinetics, Inc.

  公开号：EP1360180A1

  公开（公告）日：2003-11-12